Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp. -- Ignore unavailable to you. Want to Upgrade?

To: Karin who wrote (1263)	11/6/1998 11:47:00 PM
From: Gemini	Read Replies (1) \| Respond to of 3576

Karin, I agree with you. Everyone understands the company has enormous potential in an infinite number of areas. Then doesn't it stand to reason that one or two or several of the major drug companies would welcome the opportunity to have a serious and direct interest in Geron's success? Given the research and supporting data by Johns Hopkins and the University of Wisconsin, one would logically think that Geron is in a very strong position to negotiate very good terms with members of the pharmaceutical industry on a joint venture and/or licensing agreement basis. Can anyone say definitively that those preliminary discussions have not been taking place? All the best, Allan